Dialysis Corporation of America (DCAI) Reports In-Line Q2 EPS of $0.07

August 5, 2009 4:57 PM EDT

Dialysis Corporation of America (Nasdaq: DCAI) reports Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter was $24.7 million, versus the consensus of $24.78 million.


Related Categories

Earnings

Stocks Mentioned

DCAI 7.22

+0.01 +0.14%
Volume: 1,400
Track DCAI


Add Your Comment